# Clinical trials recruiting in Nevada: 591 (November 2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 591 trials recruiting or not yet recruiting with a site in Nevada, as read on November 19, 2026.

## The full list

Clinical trials recruiting in Nevada: 591 rows for $29.55, recruiting or not yet recruiting on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. The new rows each week by email, about 13 rows a month: $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email. The rows on this page are a sample.

Buy: https://specstream.ai/data/clinical-trials/recruiting/state/nevada

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 591
- Recruiting or not yet: 591
- Read on: November 19, 2026

## Trials

The 25 newest of 591, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| November 18, 2026 | NCT07946666 | A Clinical Trial to Evaluate the Effects of the Synbiotic Dual Cap® on Gastrointestinal Comfort in Adults Initiating GLP-1 or Dual-Incretin... | Epetome | Not applicable | Not yet recruiting | Gastrointestinal Discomfort, Nausea, Bloating, Constipation, Diarrhea, GLP-1 Receptor Agonist Therapy-Associated... | 40 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07946666) |
| November 18, 2026 | NCT07946640 | A Clinical Study to Evaluate the Effects of Driscoll's Raspberries and Driscoll's Blackberries on Postprandial Glycemic Response, Satiety... | Driscoll's | Not applicable | Not yet recruiting | Postprandial Glycemic Response, Satiety, Blood Glucose | 40 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07946640) |
| November 18, 2026 | NCT07946536 | A Clinical Trial to Evaluate the Effects of Glow Shakes Premium Collagen Meal Replacement on Nutritional Adequacy, Body Composition, Skin... | The Collagen Co. - GLP-1 Users | Not applicable | Not yet recruiting | Weight Management, Obesity, Nutritional Adequacy, Body Composition, Skin Health, Hunger and Satiety, GLP-1 Receptor... | 40 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07946536) |
| November 18, 2026 | NCT07946471 | A Clinical Trial to Evaluate the Effects of Glow Shakes Premium Collagen Meal Replacement on Body Composition, Weight Management, Skin... | The Collagen Co. - GLP-1 Users | Not applicable | Not yet recruiting | Weight Management, Body Composition, Overweight, Skin Health, Hair Health, Nail Health, Gut Health | 40 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07946471) |
| November 18, 2026 | NCT07946250 | A Clinical Trial to Evaluate the Effects of Broc Shot Capsules on Skin Appearance and Comfort in Adults With Reactive, Blemish-Prone, or... | BrocShot Inc | Not applicable | Not yet recruiting | Reactive Skin, Blemish-Prone Skin, Hormonally Affected Skin, Acne, Rosacea, Eczema, Psoriasis, Skin Irritation | 50 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07946250) |
| November 12, 2026 | NCT07931703 | Safety, Tolerability and Efficacy of RGH-202 in Social Anxiety Disorder (STAGE) | Gedeon Richter Plc. | Phase 2 | Not yet recruiting | Social Anxiety Disorder | 156 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07931703) |
| November 12, 2026 | NCT07931599 | A Research Study Investigating How Well Zenagamtide at Lower Dose Levels Lowers Blood Sugar and Body Weight Compared to Semaglutide at... | Novo Nordisk A/S | Phase 3 | Not yet recruiting | Diabetes Mellitus, Type 2 | 1,060 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07931599) |
| November 12, 2026 | NCT07931573 | AMBITION 3: A Research Study Investigating How Well Zenagamtide at Higher Dose Levels Lowers Blood Sugar and Body Weight Compared to... | Novo Nordisk A/S | Phase 3 | Not yet recruiting | Type 2 Diabetes | 1,200 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07931573) |
| November 12, 2026 | NCT07931547 | A Research Study Investigating How Well Zenagamtide Lowers Blood Sugar and Body Weight Compared to Placebo in People With Type 2 Diabetes... | Novo Nordisk A/S | Phase 3 | Not yet recruiting | Type 2 Diabetes, Chronic Kidney Disease | 450 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07931547) |
| November 10, 2026 | NCT07928245 | A Study of Brenipatide in Participants With Major Depressive Disorder | Eli Lilly and Company | Phase 2 | Not yet recruiting | Major Depressive Disorder | 330 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07928245) |
| November 10, 2026 | NCT07927907 | A Clinical Trial to Evaluate the Effects of a Supplement on Gut Health | Sponsor not shown (see the record) | Not applicable | Recruiting | Gut Health, Bloating, Digestive Discomfort, Constipation, Diarrhea, Heartburn, Abdominal Pain, Gasiness | 40 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07927907) |
| November 9, 2026 | NCT07926997 | Pharmacokinetics of Oral Zoliflodacin 3 g in Healthy Lactating Women | Global Antibiotics Research and Development Partnership | Phase 4 | Not yet recruiting | Lactation | 10 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07926997) |
| October 29, 2026 | NCT07903480 | A Clinical Trial to Evaluate the Effects of A Supplement on Symptoms of Menopause and Overall Well-being | Primal Harvest, LLC | Not applicable | Not yet recruiting | Menopause, Menopausal Symptoms, Hot Flashes, Night Sweats, Sleep Disturbance, Mood Changes, Fatigue | 40 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07903480) |
| October 28, 2026 | NCT07900633 | A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, Type 2 Diabetes, and Increased Cardiovascular Risk | Eli Lilly and Company | Phase 3 | Not yet recruiting | Obesity, Overweight, Cardiovascular Diseases, Diabetes Mellitus, Type 2 | 3,000 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07900633) |
| October 26, 2026 | NCT07893795 | A Clinical Trial to Evaluate the Effects of the NeuEve Dryness Treatment Kit on Vaginal Health, Comfort, and Quality of Life in... | NeuEve | Not applicable | Not yet recruiting | Relieves Vaginal Dryness / Improves Self-Lubrication, Improves Strength & Elasticity of Vagina (Aka Collagen and... | 40 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07893795) |
| October 26, 2026 | NCT07893626 | A Clinical Trial to Evaluate the Effects of a Children's Daily Multivitamin on Perceived Growth, Immune Health, Energy, and Focus in... | Hiya Health | Not applicable | Recruiting | Nutrient Gap in Children, Pediatric Health and Well-Being, Immune Health, Growth and Development, Energy Levels, Focus... | 40 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07893626) |
| October 26, 2026 | NCT07893561 | A Clinical Trial to Evaluate the Effects of Adrenal Adapt on Sleep Quality, Daytime Energy, Stress Resilience, and Cognitive Performance. | Bioligent | Not applicable | Recruiting | Improves Daytime Energy Levels, Reduces Afternoon Energy Crashes and Midday Fatigue, Improves Overall Sleep Quality and... | 40 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07893561) |
| October 22, 2026 | NCT07890376 | A Study to Investigate the Effect of LY4086940 Versus Placebo in Participants With Obesity or Overweight and Without Type 2 Diabetes | Eli Lilly and Company | Phase 2 | Not yet recruiting | Obesity, Overweight | 460 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07890376) |
| October 21, 2026 | NCT07885605 | Evaluation of ETHY-001 for Safety, Tolerability, and Clinical Activity in Thyroid Eye Disease | Ethyreal Bio, Inc. | Phase 1 | Recruiting | Thyroid Eye Disease (TED), Graves' Disease, Eye Diseases, Hereditary, Eye Diseases, Exophthalmos, Orbital Diseases... | 72 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07885605) |
| October 19, 2026 | NCT07881432 | A Study of EloraTZP in Adult Participants With Obesity Without Type 2 Diabetes | Eli Lilly and Company | Phase 3 | Not yet recruiting | Obesity | 2,115 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07881432) |
| October 15, 2026 | NCT07876050 | A Clinical Trial to Evaluate the Effects of the Kaia Relief - Cycle System on Premenstrual Symptom Severity, Menstrual Discomfort, and... | Vivance Group | Not applicable | Recruiting | Premenstrual Syndrome, Menstrual Discomfort, Premenstrual Symptoms | 45 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07876050) |
| October 9, 2026 | NCT07867080 | A Phase 3 Trial for Intravitreal Injection of 4D-150 in Adults With Diabetic Macular Edema (DME). | 4D Molecular Therapeutics | Phase 3 | Recruiting | Diabetic Macular Edema (DME) | 514 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07867080) |
| October 6, 2026 | NCT07861100 | A Research Study to Look at How Well Zenagamtide Works Compared to Placebo in People With Established Atherosclerotic Cardiovascular... | Novo Nordisk A/S | Phase 3 | Not yet recruiting | Cardiovascular Risk, Obesity | 8,500 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07861100) |
| September 16, 2026 | NCT07822321 | Brexanolone Lifting Outcomes Of Moms | Lipocine Inc. | Phase 3 | Recruiting | Depression, Postpartum, Postpartum Depression (PPD), Post-partum Depression, Postnatal Depression, Post-Natal... | 120 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07822321) |
| September 14, 2026 | NCT07817251 | Research Study on How People With Type 2 Diabetes Tolerate Switching From Semaglutide to Cagrisema | Novo Nordisk A/S | Phase 3 | Recruiting | Diabetes Mellitus, Type 2 | 210 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07817251) |

## Sites with the most of these trials

Sites as the records name them, organizations only.

| Site | City | Trials |
| --- | --- | --- |
| Renown Regional Medical Center | Reno | 90 |
| Comprehensive Cancer Centers of Nevada | Las Vegas | 64 |
| OptumCare Cancer Care at Charleston | Las Vegas | 45 |
| Alliance for Childhood Diseases/Cure 4 the Kids Foundation | Las Vegas | 45 |
| OptumCare Cancer Care at Fort Apache | Las Vegas | 44 |
| Summerlin Hospital Medical Center | Las Vegas | 40 |
| University Medical Center of Southern Nevada | Las Vegas | 39 |
| Sunrise Hospital and Medical Center | Las Vegas | 33 |
| Comprehensive Cancer Centers of Nevada - Central Valley | Las Vegas | 30 |
| Carson Tahoe Regional Medical Center | Carson City | 28 |
| Comprehensive Cancer Centers of Nevada - Henderson | Henderson | 27 |
| Hope Cancer Care of Nevada | Las Vegas | 26 |
| Comprehensive Cancer Centers of Nevada - Northwest | Las Vegas | 26 |
| OptumCare Cancer Care at MountainView | Las Vegas | 26 |
| Comprehensive Cancer Centers of Nevada - Town Center | Las Vegas | 26 |
| Comprehensive Cancer Centers of Nevada-Summerlin | Las Vegas | 26 |
| Comprehensive Cancer Centers of Nevada-Southeast Henderson | Henderson | 25 |
| Radiation Oncology Centers of Nevada Central | Las Vegas | 25 |
| Hope Cancer Care of Nevada-Pahrump | Pahrump | 25 |
| Saint Mary's Regional Medical Center | Reno | 25 |
| Comprehensive Cancer Centers of Nevada-Horizon Ridge | Henderson | 24 |
| Radiation Oncology Centers of Nevada Southeast | Las Vegas | 24 |
| Ann M Wierman MD LTD | Las Vegas | 24 |
| Radiation Oncology Associates | Reno | 24 |
| Cancer and Blood Specialists-Henderson | Henderson | 23 |

## By phase

| Phase | Trials |
| --- | --- |
| Phase 1 | 21 |
| Phase 1/2 | 20 |
| Phase 2 | 131 |
| Phase 2/3 | 20 |
| Phase 3 | 251 |
| Phase 4 | 23 |
| Not applicable | 67 |
| Observational | 58 |

## Conditions

| Condition group | Trials |
| --- | --- |
| Carcinoma, Non-Small-Cell Lung | 29 |
| Obesity | 29 |
| Breast Neoplasms | 26 |
| Overweight | 23 |
| Diabetes Mellitus, Type 2 | 22 |
| Depressive Disorder, Major | 17 |
| Neoplasms | 17 |
| Neoplasm Metastasis | 13 |
| Lung Neoplasms | 13 |
| Endometrial Neoplasms | 12 |
| Cardiovascular Diseases | 10 |
| Colorectal Neoplasms | 10 |
| Pancreatic Neoplasms | 10 |
| Ovarian Neoplasms | 10 |
| Hypertension | 9 |
| Pulmonary Disease, Chronic Obstructive | 9 |
| Prostatic Neoplasms | 9 |
| Crohn Disease | 9 |
| Alzheimer Disease | 8 |
| Urinary Bladder Neoplasms | 8 |
| Leukemia, Myeloid, Acute | 8 |
| Macular Degeneration | 8 |
| Geographic Atrophy | 8 |
| Triple Negative Breast Neoplasms | 7 |
| Schizophrenia | 7 |

## Sponsors with the most

| Sponsor | Trials |
| --- | --- |
| [Eli Lilly and Company](https://specstream.ai/data/clinical-trials/company/eli-lilly-and-company) | 26 |
| National Cancer Institute (NCI) | 25 |
| [AstraZeneca](https://specstream.ai/data/clinical-trials/company/astrazeneca) | 24 |
| [Merck Sharp & Dohme LLC](https://specstream.ai/data/clinical-trials/company/merck-sharp-and-dohme-llc) | 20 |
| Children's Oncology Group | 17 |
| [Pfizer](https://specstream.ai/data/clinical-trials/company/pfizer) | 16 |
| NRG Oncology | 15 |
| [AbbVie](https://specstream.ai/data/clinical-trials/company/abbvie) | 14 |
| [Bristol-Myers Squibb](https://specstream.ai/data/clinical-trials/company/bristol-myers-squibb) | 12 |
| SWOG Cancer Research Network | 12 |
| [Sanofi](https://specstream.ai/data/clinical-trials/company/sanofi) | 11 |
| [Hoffmann-La Roche](https://specstream.ai/data/clinical-trials/company/hoffmann-la-roche) | 11 |
| Alliance for Clinical Trials in Oncology | 11 |
| [Novo Nordisk A/S](https://specstream.ai/data/clinical-trials/company/novo-nordisk-a-s) | 11 |
| University of Nevada, Las Vegas | 10 |
| [GlaxoSmithKline](https://specstream.ai/data/clinical-trials/company/glaxosmithkline) | 9 |
| [Boehringer Ingelheim](https://specstream.ai/data/clinical-trials/company/boehringer-ingelheim) | 8 |
| [Axsome Therapeutics, Inc.](https://specstream.ai/data/clinical-trials/company/axsome-therapeutics-inc) | 6 |
| [Amgen](https://specstream.ai/data/clinical-trials/company/amgen) | 5 |
| Tempus AI | 5 |
| [Regeneron Pharmaceuticals](https://specstream.ai/data/clinical-trials/company/regeneron-pharmaceuticals) | 4 |
| [Vanda Pharmaceuticals](https://specstream.ai/data/clinical-trials/company/vanda-pharmaceuticals) | 4 |
| [Janssen Research & Development, LLC](https://specstream.ai/data/clinical-trials/company/janssen-research-and-development-llc) | 4 |
| [Novartis Pharmaceuticals](https://specstream.ai/data/clinical-trials/company/novartis-pharmaceuticals) | 4 |
| [Takeda](https://specstream.ai/data/clinical-trials/company/takeda) | 4 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in Nevada

- [Broadcast media production companies in Nevada, United States](https://specstream.ai/data/businesses/broadcast-media-production-companies/nevada-united-states)
- [Restaurants in Nevada, United States](https://specstream.ai/data/businesses/restaurants/nevada-united-states)
- [Interior design firms in Nevada, United States](https://specstream.ai/data/businesses/interior-design-firms/nevada-united-states)
- [Chicken wings restaurants in Nevada, United States](https://specstream.ai/data/businesses/chicken-wings-restaurants/nevada-united-states)
- [Surgery centers in Nevada, United States](https://specstream.ai/data/businesses/surgery-centers/nevada-united-states)
- [Lawn care companies in Nevada, United States](https://specstream.ai/data/businesses/lawn-care-companies/nevada-united-states)
